|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1992-2-5
|
|
pubmed:abstractText |
Central to the neural mechanism of MPTP-induced parkinsonism is overactivity of the subthalamic nucleus. Lesion of the subthalamic nucleus has therefore been performed in two primates with this condition and found to produce a remarkable amelioration of the disorder.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0885-3185
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
288-92
|
|
pubmed:dateRevised |
2003-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:1758446-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,
pubmed-meshheading:1758446-Animals,
pubmed-meshheading:1758446-Brain Mapping,
pubmed-meshheading:1758446-Dominance, Cerebral,
pubmed-meshheading:1758446-Macaca fascicularis,
pubmed-meshheading:1758446-Neurologic Examination,
pubmed-meshheading:1758446-Parkinson Disease, Secondary,
pubmed-meshheading:1758446-Radiosurgery,
pubmed-meshheading:1758446-Thalamic Nuclei
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate.
|
|
pubmed:affiliation |
Department of Cell and Structural Biology, University of Manchester Medical School, U.K.
|
|
pubmed:publicationType |
Journal Article
|
